CannabisNewsBreaks

TuesdayFeb 15, 2022 12:37 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has appointed Gerard (Jerry) P. Griffin III as vice president of sales and marketing at BayMedica, a wholly owned subsidiary of InMed. In his new role, Griffin will manage the commercialization of BayMedica’s health and wellness business including existing products as well as the launch of new products. Griffin brings a rich background to this position, having a proven track record as a veteran sales executive. He has served in several senior positions in Fortune 500 companies, including most recently as VP of sales…

Continue Reading

MondayFeb 14, 2022 2:28 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies

InMed Pharmaceuticals (NASDAQ: INM) understands the immense potential of rare cannabinoids and sees them as having applications as wide as cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), variants of cannabinoids that make up most of the content in cannabis plants. Studies suggest that rare cannabinoids could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. “However, the industry wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. The answer is…

Continue Reading

MondayFeb 14, 2022 2:08 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Furthering Global Foothold as Leader in Plant-Based Wellness, Lifestyle Brands

Flora Growth Corp. (NASDAQ: FLGC) is expanding its cannabis-derived brand presence in Latin American countries. Its Mind Naturals skincare brand, built with premium CBD and other high-quality ingredients, will be distributing a portfolio of 12 products through its agreement with Walmart’s online marketplace and Coppel e-commerce outlets. Walmart and Coppel are leading retail chains in Mexico and Central America. A recent article quotes Flora Growth CEO Luis Merchan as saying, “This agreement represents our first foray into the Mexican market and furthers our global foothold as a leader in plant-based wellness and lifestyle brands… As the cannabis market continues its…

Continue Reading

FridayFeb 11, 2022 2:28 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Attentive as Broad Federal Cannabis Decriminalization Agenda Gets off the Ground

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is closely watching the growing bipartisan support for federal cannabis reform. A recent article, which contains excerpts from a December 2021 write-up in the National Law Review (“NLR”), reads, “‘Long-anticipated federal cannabis reform may be on the horizon… In the last month, bipartisan governors and groups from both bodies of Congress have established support for cannabis policies that would reshape federal enforcement and set the stage for further state legalization.’ The article specifically noted the States Reform Act, which was introduced by South Carolina Representative Nancy Mace in November;…

Continue Reading

FridayFeb 11, 2022 1:13 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) to Be Evaluated for Potential Treatment Options for Multiple Conditions

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Chris Bunka noted that Lexaria would continue to see significant milestones in utilizing its patented DehydraTECH drug delivery technology in 2022. “Calendar 2022 will continue to see significant milestones utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking… We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease and diabetes,” a recent article quotes Bunka as saying. Lexaria received independent review board approval, marking…

Continue Reading

FridayFeb 11, 2022 10:40 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Host CBD and the Global Market Webinar

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, has announced that it will hold a webinar today, Feb.11, at 1:00 p.m. ET. The CBD and the Global Market webinar will be the first of the company’s “State of Play” series. During the webinar, Flora CEO Luis Merchan will explore the opportunities and challenges that lie ahead for the CBD industry in North America, Latin America and the EU. Interested parties should visit https://cnw.fm/tSRGL and, upon registration, can submit questions in advance of the event. To view the full press release, visit https://cnw.fm/LqF2l About Flora Growth…

Continue Reading

ThursdayFeb 10, 2022 1:01 pm

CannabisNewsBreaks – O’Cannabiz International Event Returns to Toronto in June

The O’Cannabiz International Awards, Conference and Expo presented by ND Supplies is heading back to Toronto this year; the three-day event is scheduled for June 1–3, 2022. The event has built a reputation for providing a high-level lineup of exhibitors, speakers and conference topics designed to cover innovative and informative research and the latest in technology. The event also offers invaluable networking opportunities that enable conference participants to rub shoulders with cannabis industry professionals and experts from around the world. This year’s event will also feature new core elements with educational programming delivered on three separate stages. Topics covered will…

Continue Reading

ThursdayFeb 10, 2022 12:21 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company's IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product…

Continue Reading

WednesdayFeb 09, 2022 12:43 pm

CannabisNewsBreaks – VPR Brands LP (VPRB) Unveils New Dissim Sport and Dissim Slim Lighters to ‘Best Focus Group’ for Pre-Launch Reaction

VPR Brands (OTC: VPRB) recently debuted its new Dissim Sport and Dissim Slim Line Lighters at the 2022 TPE Tobacco Plus Expo, held in Las Vegas from Jan. 26-28, 2022, and the Champs Trade Show on Feb. 2-5, 2022, at the Las Vegas Convention Center. According to the update, the Slim and Sport line within the Dissim family of lighters will launch with an opening price point between $8-$28 MSRP respectively and are expected to bring a new audience and open new distribution channels. “I personally attended TPE this year so I could interact with the distributors firsthand and gauge…

Continue Reading

TuesdayFeb 08, 2022 2:59 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Reaches ‘Major Milestone,’ Closes on Acquisition

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, through its wholly owned subsidiary RWB Michigan LLC, has closed on the acquisition of PharmaCo Inc. The acquisition, which was originally announced in 2020, brings an extensive list of assets to RWBYF, including 21 medical and adult-use cannabis licenses, eight fully operating dispensaries with five dually licensed, two operational indoor cultivation facilities totaling more than 30,000 square feet, one municipally licensed 10-acre outdoor cultivation facility ready for the 2022 season, two ready-to-open dispensaries, and22 owned properties for potential additional cultivation and dispensary locations.…

Continue Reading